Pfizer Inc., PFE is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Pfizer Inc., PFE has a market cap of 193701.73. Since its IPO date on the 6/1/1972, Pfizer Inc., PFE performance year to date is 2.62%. Today Pfizer Inc., PFE has gained -0.19%, with a current price of 31.86.
Ownership of the company is 0.04% for insider ownership while institutional ownership is 70.60%. The management of the company have seen the company have a payout ratio of 116.50%. Return of assets are at 3.60%, with return on investment at 7.30%.
In terms of debt levels and profit levels, Pfizer Inc., PFE is seeing a long-term debt/equity of 0.48. While Total debt/equity is 0.7. With a profit margin of 11.60%, this is combined with a gross margin of 76.60%, and operating margin of 15.10%. Pfizer Inc. ability to meet debt levels, with a current ratio of 1.1, while the quick ratio is 0.9.
For the last year Pfizer Inc., PFE has seen a EPS growth of -21.50%. A performance for the year of 1.09%. The 52-week high is -13.22%, and the 52-week low is 15.88%. The average volume for Pfizer Inc., PFE is 3075587.
With a target price of 37.86, can Pfizer Inc., PFE reach this target? Looking at the value indicators of Pfizer Inc., PFE. Pfizer Inc. has a P/E of 31.86 and a forward P/E of 12.17. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.05. Pfizer Inc. also has a P/S and a P/B of 3.64 and 3.06 respectively. For P/cash, Pfizer Inc. has a value of 13.48, while it is 108.76 for P/free cash flow.
At the current price of 31.86, Pfizer Inc. has a dividend yield of 3.76%. We see a return on equity of 9.70%.
Looking more long-term Pfizer Inc., is projected to get an EPS growth for the next five years of 6.31%. In the short-term an EPS growth of 8.70% in the next year is forecasted. This is after a EPS growth of -21.50% for this year and for the last five years a 1.60% growth has been seen.